HIF1A and breast carcinoma: In a study of CTCs obtained from breast cancer patients, VEGF and its upstream regulators HIF-1 and phosphorylated-focal adhesion kinase (pFAK) are expressed in 73%, 56%, and 81% of detected CTCs, respectively [35].